⟳ Репост от Jon Salmanton-García
Mycological diagnostics in Australia & NZ vary widely. Key non-culture tests are often offsite, β-D-glucan access is rare, and antifungal resistance surveillance remains limited. Important gaps in regional capability. 🔗 www.sciencedirect.com/science/arti... #Mycology @salmantongarcia.bsky.social
Mycological testing in Australasian clinical mycology laboratories: survey of the current state and access to testingAccess to mycological diagnostics varies across clinical laboratories. This study aimed to assess the availability of key fungal diagnostic methods in…www.sciencedirect.com